Binding of plasminogen to cultured human endothelial cells - PubMed (original) (raw)

. 1986 Sep 5;261(25):11656-62.

PMID: 3745161

Free article

Binding of plasminogen to cultured human endothelial cells

K A Hajjar et al. J Biol Chem. 1986.

Free article

Abstract

Endothelial cells are known to release the two major forms of plasminogen activator, tissue plasminogen activator (TPA) and urokinase. We have previously demonstrated that plasminogen (PLG) immobilized on various surfaces forms a substrate for efficient conversion to plasmin by TPA (Silverstein, R. L., Nachman, R. L., Leung, L. L. K., and Harpel, P. C. (1985) J. Biol. Chem. 260, 10346-10352). We now report the binding of human PLG to cultured human umbilical vein endothelial cell (HUVEC) monolayers, utilizing a newly devised cell monolayer enzyme-linked immunosorbent assay system. PLG binding to HUVEC was concentration dependent and saturable at physiologic PLG concentration (2 microM). Binding of PLG was 70-80% inhibited by 10 mM epsilon-aminocaproic acid, suggesting that it is largely mediated by the lysine-binding sites of PLG. PLG bound at an intermediate level to human fibroblasts, poorly to human smooth muscle cells, and not at all to bovine smooth muscle or bovine endothelial cells; unrelated proteins such as human albumin and IgG failed to bind HUVEC. PLG binding to HUVEC was rapid, reaching a steady state within 20 min, and quickly reversible. 125I-PLG bound to HUVEC with an estimated Kd of 310 +/- 235 nM (S.E.); each cell contained 1,400,000 +/- 1,000,000 (S.E.) binding sites. Functional studies demonstrated that HUVEC-bound PLG is activatable by TPA according to Michaelis-Menten kinetics (Km, 5.9 nM). Importantly, surface-bound PLG was activated with a 12.7-fold greater catalytic efficiency than fluid phase PLG. These results indicate that PLG binds to HUVEC in a specific and functional manner. Binding of PLG to endothelial cells may play a pivotal role in modulating thrombotic events at the vessel surface.

PubMed Disclaimer

Cited by

Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2).
Das M, Ithychanda SS, Plow EF. Das M, et al. Biomolecules. 2022 Jan 26;12(2):211. doi: 10.3390/biom12020211. Biomolecules. 2022. PMID: 35204713 Free PMC article.
The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.
Kumar AA, Buckley BJ, Ranson M. Kumar AA, et al. Biomolecules. 2022 Jan 18;12(2):152. doi: 10.3390/biom12020152. Biomolecules. 2022. PMID: 35204653 Free PMC article. Review.
Metal Ions Bound to Prion Protein Affect its Interaction with Plasminogen Activation System.
Borumand M, Ellis V. Borumand M, et al. Protein J. 2022 Feb;41(1):88-96. doi: 10.1007/s10930-021-10035-4. Epub 2022 Jan 17. Protein J. 2022. PMID: 35038117 Free PMC article.
SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.
Gerzanich V, Kwon MS, Woo SK, Ivanov A, Simard JM. Gerzanich V, et al. PLoS One. 2018 Apr 4;13(4):e0195526. doi: 10.1371/journal.pone.0195526. eCollection 2018. PLoS One. 2018. PMID: 29617457 Free PMC article.
Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.
Viedma-Rodríguez R, Martínez-Hernández MG, Flores-López LA, Baiza-Gutman LA. Viedma-Rodríguez R, et al. Mol Cell Biochem. 2018 Jan;437(1-2):65-80. doi: 10.1007/s11010-017-3096-8. Epub 2017 Jun 13. Mol Cell Biochem. 2018. PMID: 28612231

Binding of plasminogen to cultured human endothelial cells - PubMed (original) (raw)